Phase III clinical trial - Prostate

PEACE 2 (GETUG - AFU 23)
Prostate
Ouvert depuis le: 07.22.2019
Site: Paris
Public cible
Adulte
A Randomized Phase III, Factorial Design, of Cabazitaxel and Pelvic Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse.
Description de l'essai

The objective of this study is to assess the effect of neoadjuvant cabazitaxel and pelvic radiotherapy in combination with ADT-radiotherapy on clinical progression-free survival in patients with high-risk localized prostate cancer (with a stringent selection of patients with at least 2 high-risk features), in a 2 by 2 factorial trial.